MedTrace Logo

Collective Motivational Interviewing (CMI) for Adolescents With Internet Gaming Disorder

NCT05917977 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 172

Last updated 2024-10-03

No results posted yet for this study

Summary

The present study examines the efficacy of CMI in reducing adolescent IGD symptoms and enhancing social support given by CSOs among adolescents with high risk of IGD (probable IGD cases screened positive by validated tools). It is hypothesized that the intervention group (with CMI plus IGD education materials for both the clients and his/her selected CSO) would show more improvements in reduction in the severity of IGD, motivation to change maladaptive gaming behaviour, craving on gaming, and social support obtained from CSOs than to the control group (only educational materials for both the client and the CSOs).

Conditions

  • Internet Gaming Disorder

Interventions

BEHAVIORAL

Collective Motivational Interviewing plus Education Materials

The participants in the intervention group will receive IGD educational materials as well as four counseling sessions of CMI intervention.

OTHER

Control group (Education Materials)

The participants in the control group will receive IGD educational materials.

Sponsors & Collaborators

  • The University of Hong Kong

    collaborator OTHER

  • Chinese University of Hong Kong

    collaborator OTHER

  • Nottingham Trent University

    collaborator OTHER

  • Fudan University

    collaborator OTHER

  • Hong Kong College of Technology

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2025-12-31
Completion
2026-12-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05917977 on ClinicalTrials.gov